Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2025-12-25 @ 8:58 PM
NCT ID:
NCT01896856
Group ID:
EG006
Title:
Phase 2: Arm B Regorafenib or TAS-102
Description:
Subjects received either regorafenib or TAS-102. Regorafenib 160 mg was taken orally daily from days 1-21 of each 28-day cycle or TAS-102 35 mg/m\^2 was taken orally twice daily on days 1-5 and 8-12 of each 28-day cycle.
Subjects that had previously received one of these standard of care drugs (regorafenib or TAS-102) received the other on study. For subjects that had never received either regorafenib or TAS-102, the choice of therapy was deferred to the treating physician and patient.
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
34
Other Number Affected:
30
Other Number At Risk:
34
Study:
NCT01896856
Results Section:
NCT01896856
Adverse Events Module:
NCT01896856